Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Nasal Polyps

1-methyl-3-isobutylxanthine has been researched along with Nasal Polyps in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Nasal Polyps: Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Quesnel, LB1
Jaran, AS1
Braganza, JM1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Nasal Polyps

ArticleYear
Antibiotic accumulation and membrane trafficking in cystic fibrosis cells.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1-Methyl-3-isobutylxanthine; Adenosine Triphosphate;

1998